Correspondence 0001640334-23-000767 from Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362) (LEXX)
Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362)
Date: May 4, 2023 · CIK: 0001348362 · Accession: 0001640334-23-000767
AI Filing Summary & Sentiment
File numbers found in text: 333-271096
Show Raw Text
CORRESP
1
filename1.htm
mlfb_rw.htm
Lexaria Bioscience Corp.
100-740 McCurdy Road, Kelowna
British Columbia, Canada, V1X 2P7
May 4, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington, D.C. 20549
Attention: Tyler Howes
Re:
Lexaria Bioscience Corp
Registration Statement on Form S-1, as amended
Initially filed on April 3, 2023, as amended on April 28, 2023
File No. 333-271096 (the “Registration Statement”)
Withdrawal Request for Acceleration
Ladies and Gentlemen:
We hereby request the withdrawal of our request for acceleration, dated May 3, 2023, of the effective date of the Registration Statement on Form S-1, as amended (File No. 333-271096) that was requested to become effective at 9:00 a.m. Eastern Time, on May 5, 2023, or as soon thereafter as practicable. We hereby respectfully withdraw this acceleration request at this time.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Sichenzia Ross Ference LLP, attention: Avital Perlman, Esq. at (212) 930-9700.
Very truly yours,
LEXARIA BIOSCIENCE CORP
By:
/s/ Christopher Bunka
Christopher Bunka
Chief Executive Officer